JPET xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by CANTONI, G. L.
Right arrow Articles by BERNHEIMER, A. W.
Right arrow Search for Related Content
PubMed
Right arrow Articles by CANTONI, G. L.
Right arrow Articles by BERNHEIMER, A. W.
Journal of Pharmacology And Experimental Therapeutics, Vol. 91, Issue 1, 31-38, 1947
Copyright © 1947 by American Society for Pharmacology and Experimental Therapeutics


THE TOXIC ACTION OF PREPARATIONS CONTAINING THE OXYGEN-LABILE HEMOLYSIN OF STREPTOCOCCUS PYOGENES

IV. COMPARISON OF CARDIOTOXIC ACTION WITH THAT OF SAPONIN

G. L. CANTONI 1 and ALAN W. BERNHEIMER 1

1 From the Department of Pharmacology, Long Island College of Medicine, Brooklyn, New York and the Department of Bacteriology, New York University College of Medicine, New York, New York

1. The cardiotoxic action of saponin has been compared with that of preparations containing the oxygen-labile hemolysin of streptococci.

2. Exposure of the heart to a single application of the streptococcal preparation (SPA) increases the responsiveness of the heart to saponin. Conversely, exposure of a heart to a subcontracturing dose of saponin increases its responsiveness to SPA.

3. Exposure of the heart to a mixture of the two agents produces an effect, systolic contracture, which is not elicited by either agent acting alone in the same concentration.

4. Exposure of the heart to a single application of SPA sensitizes the heart to a second application of SPA. Exposure of a heart to a comparable concentration of saponin fails to sensitize to a second application of saponin.

5. The hemolytic actions of SPA and saponin are not additive.

6. Release of an inhibitor accompanies the first exposure of a heart to SPA, but does not accompany exposure of a heart to saponin in any of the concentrations tested.

7. Inhibitor-fluid prevents the contracturing action of SPA, but prevents neither the contracturing action of saponin nor the sensitizing action of SPA.

8. It is postulated that the ultimate site of action of the cardiotoxic agents is normally covered by two barriers, one of which can be displaced by saponin, the other by SPA, and that exposure of the ultimate site of action must occur before either agent can produce systolic contracture.

Submitted on May 28, 1947







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1947 by the American Society for Pharmacology and Experimental Therapeutics.